Financial Tearsheet






Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Chart

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

10 May 22
Cronos Group Inc. Announces Conference Participation for May 2022
TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Office, will speak at two upcoming conferences: Canaccord
10 May 22
Cronos Group Reports 2022 First Quarter Results
Consolidated net revenue increased by 99% year-over-year to $25.0 million in Q1 2022 Israel net revenue increased by 263% year-over-year to $9.1 million in Q1 2022 Increased market share in Canada and Israel in Q1 2022 Mike Gorenstein returned as Chief Executive Officer TORONTO, May 10, 2022 (GLOBE
29 Apr 22
Cronos Group Inc. to Hold Virtual 2022 Annual Meeting of Shareholders
TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2022 Annual Meeting of Shareholders on Thursday, June 23, 2022, at 11:00 a.m. ET. Cronos Group will be conducting the meeting in a virtual-only format via live

SEC Filings

Filing date Description

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Report of unscheduled material events or corporate event

Events

08 May 2020 at 8:30 AM EDT
Cronos Group First Quarter 2020 Earnings Conference Call